Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems


Finger R. P. , Daien V., Eldem B. M. , Talks J. S. , Korobelnik J., Mitchell P., ...Daha Fazla

BMC OPHTHALMOLOGY, cilt.20, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Background: Systematically review the evidence describing the impact of anti-vascular endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular degeneration (nAMD) patient outcomes and healthcare resource utilization.